Back

Clinical impact of endovascular therapy with paclitaxel-based strategy for femoropopliteal lesions in chronic limb-threatening ischaemia

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Peripheral angioplasty and complications Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Hiroaki Nohara

Osaka Rosai Hospital, Sakai (Japan)

4 More presentations in this session

Presentation thumbnail
Pathology of balloon angioplasty for below the knee arteries in patients with chronic limb threatening ischemia
Doctor M. Shiozaki (Kanagawa, JP)
Abstract Slides Video
Presentation thumbnail
The predictors of clinical outcome in the patients undergoing endovascular intervention for lower extremity peripheral arterial disease
Professor B. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Sirolimus vs paclitaxel for femoropopliteal peripheral artery disease - The limus flow randomized trial
Professor C. Rammos (Essen, DE)
Abstract Slides Video
Presentation thumbnail
Long-term prognosis after bypass surgery versus endovascular therapy in chronic hemodialysis patients with peripheral artery disease -10-year follow-up study
Doctor Y. Kumada (Kasamatsu, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Peripheral angioplasty and complications

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Factors affecting in-hospital clinical outcomes in patients with acute limb ischemia undergoing endovascular therapy or fogarty thrombectomy: a large-scale analysis based on the JROAD-DPC database
thumbnail
Congress Presentation
Impact of cilostazol on clinical outcomes in lower extremity arterial disease patients after angioplasty: a real-world analysis
thumbnail
Congress Presentation
Patient and procedural characteristics of successful endovascular procedures in the BEST-CLI Trial and their relationship to major adverse limb events

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources